Patients with so-called high-grade prostate cancer often struggle with severe side effects after a standard treatment. Our data shows that IRE as a treatment method is much gentler, but just as efficient as standard therapies. The VITUS Prostate Center has presented current data at this year’s World Congress of Electroporation for the treatment of high-grade prostate cancer (PCa) using Irreversible Electroporation (IRE). The promising results are based on a retrospective observational study of the first 113 patients with high-grade PCa treated at the VITUS Prostate Center with a follow-up p ..read more

Radioligand therapy (RLT) using Lu-177 labelled PSMA is a novel and promising therapeutic approach to treat metastatic prostate cancer. We explain how the therapy works. Lu-177 PSMA Therapy is an emerging therapeutic method for the palliative treatment of advanced metastatic prostate cancer, which is offered as an individual medical treatment. An individual medical treatment is the application of an effective but not (yet) approved therapy, which can be carried out in individual cases and in patients where other therapeutic measures have been exhausted. An individual medical treatment is cl ..read more

Prostate cancer is the most common cancer in men, affecting 25% of all men. The standard treatments are time-consuming and associated with significant side effects. A new retrospective study shows: Irreversible Electroporation (IRE) makes it possible to treat prostate cancer more efficiently, more specifically and with fewer side effects. Prostate cancer, with an estimated 307,000 annual deaths worldwide, is the fifth leading cause of death from cancer in men (6.6% of total deaths). Standard treatments are the surgical removal of the prostate (radical prostatectomy = RPE) and radiation ther ..read more